申请人:Tanabe Seiyaku Co., Ltd.
公开号:US04612317A1
公开(公告)日:1986-09-16
Tetrahydro-.beta.-carboline derivatives of the formula: ##STR1## wherein R.sup.1 is hydrogen atom, a lower alkyl group, a cycloalkyl group, phenyl group or a hydroxy-substituted lower alkyl group, R.sup.2 is hydrogen atom, an alkyl group, or a group of the formula: --(CH.sub.2).sub.m Y, Y is thienyl or a substituted or unsubstituted phenyl group, and m and n are an integer of 1 or 2, which have excellent alleviating, curing and preventing hepatic damages and are useful as a therapeutic or prophylactic agent for hepatic diseases, and a process for the preparation of said compounds.
Tetrahydro-.beta.-carboline衍生物的化学式如下:##STR1##其中R.sup.1是氢原子,较低的烷基基团,环烷基基团,苯基或羟基取代的较低烷基基团,R.sup.2是氢原子,烷基基团,或化学式--(CH.sub.2).sub.m Y的基团,Y是噻吩基或取代或未取代的苯基团,m和n是1或2的整数,这些化合物具有出色的缓解、治愈和预防肝损伤的作用,并可用作治疗或预防肝病的药物,以及制备上述化合物的方法。